Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
The development of drug resistance is one of the main causes of failure in anti-cancer treatments. Tumor cells adopt many strategies to counteract the action of chemotherapeutic agents, e.g., enhanced DNA damage repair, inactivation of apoptotic pathways, alteration of drug targets, drug inactivatio...
Main Authors: | Theo Battista, Annarita Fiorillo, Valerio Chiarini, Ilaria Genovese, Andrea Ilari, Gianni Colotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/4/887 |
Similar Items
-
Sorcin, a Calcium Binding Protein Involved in the Multidrug Resistance Mechanisms in Cancer Cells
by: Gianni Colotti, et al.
Published: (2014-09-01) -
Sorcin: a novel potential target in therapies of cancers
by: Zhou X, et al.
Published: (2019-08-01) -
Regulation of cardiac excitation-contraction coupling by sorcin, a novel modulator of ryanodine receptors
by: EMILY F FARRELL, et al.
Published: (2004-01-01) -
Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance
by: Xiaokun Wang, et al.
Published: (2019-12-01) -
Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
by: Maria Berrocal, et al.
Published: (2021-06-01)